Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs)
$104.47
pos +0.63
+0.61%
Today's Range: 104.34 - 104.81 | GILD Avg Daily Volume: 13,114,400
Last Update: 09/18/14 - 9:31 AM EDT
Volume: 328,444
YTD Performance: 0.00%
Open: $104.63
Previous Close: $103.84
52 Week Range: $58.81 - $110.64
Oustanding Shares: 1,511,670,456
Market Cap: 158,362,596,971
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 13 15
Moderate Buy 1 1 1 2
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.31 1.32
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
0.00 23.50 28.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.50 0.41 0.12
Net Income 18.80 0.06 0.02
EPS 10.80 0.18 0.06
Earnings for GILD:
EBITDA 4.87B
Revenue 11.20B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.64 $2.22 $7.26 $9.07
Number of Analysts 3 3 3 3
High Estimate $1.85 $2.81 $8.34 $10.13
Low Estimate $1.35 $1.52 $5.51 $7.31
Prior Year $0.50 $0.52 $1.92 $7.26
Growth Rate (Year over Year) 227.33% 326.28% 278.30% 24.83%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Dan Fitzpatrick

 | Sep 17, 2014 | 7:35 AM EDT

With the market at its highs and the massive risk, that's what being a money manager currently entails.

By

David Katz

 | Sep 12, 2014 | 11:44 AM EDT

 Hepatitis C therapies are the pacesetters.

By

Bret Jensen

 | Sep 9, 2014 | 10:00 AM EDT

I caught two such trades in the past few days by staying light on my feet.

By

Doug Kass

 | Sep 5, 2014 | 12:44 PM EDT
Who DOESN'T like Gilead (GILD)?

updateBaird Healthcare Conf.

Sep 4, 2014 | 7:34 AM EDT

Robert W. Baird & Co. Inc Health Care Conference (Day 2 of 2) - 09/03/14 - 09/04/14 New York City, NY

updateCiti Biotech Conf.

Sep 3, 2014 | 6:56 AM EDT

Citi Biotech Conference 

By

Jim Cramer

 | Sep 2, 2014 | 6:53 AM EDT

Yep, the bets for the rest of 2014 are being placed.

By

Jim Cramer

 | Aug 29, 2014 | 9:34 AM EDT

Here's how you can get on the bandwagon.

By

Bret Jensen

 | Aug 28, 2014 | 10:30 AM EDT

I'd advise picking up these two stocks before year-end.

By

Gary Dvorchak

 | Aug 21, 2014 | 2:08 PM EDT
For accountability's sake, here is an update on my on my current five best ideas.
Can the U.S. balance its trade deficit by exporting bad ideas? Xinhua is carrying a story...
Stocks to watch this morning include… Rite Aid has it wrong today with an earnings ...
USA Housing Starts (MoM) for Aug -14.40% vs -5.20% Est; Prior Revised from 15.70% to 22.90...
Market is set to open higher as the Scots head to the polls to vote on the independence qu...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.